Photo Rounds

White vaginal areas

A 59-year-old woman with a history of condyloma presented to her family physician (FP) with vaginal itching. In addition to a cystocele after her hysterectomy, she had a Trichomonas infection and evidence of atrophic changes. The white areas at the 6, 11, and 12 o’clock positions were concerning. She’d had one sexual partner in the previous 6 months.

What's your diagnosis?


 

The FP recognized the white areas as leukoplakia suggestive of vulvar intraepithelial neoplasia (VIN). Punch biopsies showed moderate vulvar intraepithelial neoplasia II (VIN II) along with associated human papillomavirus (HPV) changes.

More than 50% of patients presenting with vulvar dysplasia have no symptoms. When symptoms are present, pruritus is the most common one. Unlike cervical intraepithelial neoplasia, VIN is usually multifocal. The most common locations include the interlabial grooves, posterior fourchette, and the perineum. Since VIN can appear warty, lesions that are diagnosed as condyloma (as was the case with this patient) and that don’t respond to conservative therapy should be biopsied to rule out VIN.

Biopsy to exclude invasive disease is mandatory prior to any topical treatment. Patients with VIN II or III should have their lesions removed. Basaloid and warty VINs may be treated with ablation on non–hair-bearing epithelium. A CO2 laser is typically used to remove the lesions, although some physicians perform a loop electrosurgical excision procedure.

Alternatives to surgery and laser include topical agents. 5-Fluorouracil cream, which causes a chemical desquamation of the lesion, has traditionally been used to treat VIN. It may result in significant burning, pain, inflammation, edema, and occasional painful ulcerations. Imiquimod cream is a topical immune response modifier that is FDA approved for the treatment of anogenital warts, actinic keratosis, and certain basal cell carcinomas. It has been used to treat multifocal VIN II or III in a few small pilot studies. The cream is self-administered 3 times per week for periods of 6 to 34 weeks.

In this case, the patient was referred for treatment of the VIN and given 2 g of oral metronidazole for the Trichomonas infection. She was advised to inform her most recent sexual partner about the Trichomonas infection so that he might receive treatment. Testing for other sexually transmitted diseases was negative.

Photo and text for Photo Rounds Friday courtesy of Richard P. Usatine, MD. This case was adapted from: Mayeaux EJ. Vulvar intraepithelial neoplasia. In: Usatine R, Smith M, Mayeaux EJ, et al, eds. Color Atlas of Family Medicine. 2nd ed. New York, NY: McGraw-Hill; 2013:519-524.

To learn more about the Color Atlas of Family Medicine, see: http://www.amazon.com/Color-Family-Medicine-Richard-Usatine/dp/0071769641/

You can now get the second edition of the Color Atlas of Family Medicine as an app by clicking on this link: http://usatinemedia.com/

Recommended Reading

ICSI use without male factor infertility climbs, but births decline
MDedge Family Medicine
Data scarce on risk modifiers for second primary cancers
MDedge Family Medicine
Bright red cervix
MDedge Family Medicine
Aromatase inhibitors linked to cardiovascular disease
MDedge Family Medicine
CDC: Opioid use high among reproductive age women
MDedge Family Medicine
FDA’s new labeling rule: clinical implications
MDedge Family Medicine
Perinatal mood and anxiety disorders
MDedge Family Medicine
ACOG outlines new treatment options for hypertensive emergencies in pregnancy
MDedge Family Medicine
Few ACA marketplaces offer plans with abortion coverage
MDedge Family Medicine
Tight hypertension control in pregnancy not tied to better outcomes
MDedge Family Medicine